OPK
- OPKO Health, Inc.
()
Overview
Company Summary
OPKO Health, Inc. (OPK) is a multinational healthcare company that specializes in the development and commercialization of diagnostic and pharmaceutical products. The company operates in several areas of healthcare, including diagnostics, biologics, and pharmaceuticals.
One of OPKO Health's primary focuses is on diagnostics. They develop and sell a range of diagnostic tests and equipment that aid in the detection and monitoring of various medical conditions. Their diagnostic products cover a wide range of fields, including genetics, urology, oncology, and infectious diseases.
In addition to diagnostics, OPKO Health is also involved in the development of biologics. Biologics are complex drugs derived from living organisms and have revolutionized the treatment of several diseases, including cancer and autoimmune disorders. OPKO Health develops and commercializes innovative biologic therapies, including long-acting human growth hormone (hGH) products.
OPKO Health also has a presence in the pharmaceutical industry. They research, develop, and manufacture pharmaceutical drugs, with a focus on therapeutic areas such as ophthalmology, nephrology, and neurology. Their pharmaceutical products range from therapeutic treatments for chronic kidney disease and retinal disorders to pain management medication.
Moreover, OPKO Health has made strategic acquisitions and collaborations to expand its product portfolio and geographical reach. They actively pursue partnerships to bring cutting-edge technologies and treatments to market.
Overall, OPKO Health, Inc. is a diversified healthcare company that strives to improve patient care through the development and commercialization of innovative diagnostics, biologic therapies, and pharmaceutical drugs across multiple therapeutic areas.